Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis.

@article{Fardellone2010CosteffectivenessMO,
  title={Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis.},
  author={Patrice Fardellone and Bernard Cortet and Erick Legrand and Xavier Bresse and S{\'e}gol{\`e}ne Bisot-Locard and Anne-Marie Vigneron and Ariel Beresniak},
  journal={Joint, bone, spine : revue du rhumatisme},
  year={2010},
  volume={77 1},
  pages={53-7}
}
OBJECTIVES To compare effectiveness, associated cost of outcomes and cost-effectiveness of a single annual infusion of zoledronic acid versus current treatment strategies plans for postmenopausal osteoporosis in France. METHODS Twelve simulation-based models were built to investigate three types of fractures: vertebral (VF), non-vertebral excluding hip (NVF) and hip (HF), comparing two groups: zoledronic acid and current postmenopausal antiosteoporotic treatment strategies. Two effectiveness… CONTINUE READING

Similar Papers

Loading similar papers…